Almirall Partners with CrystalO to Discover Novel Dermatology Drugs
Barcelona, Spain, August 9, 2026 Almirall announced a collaboration and licensing agreement with CrystalO, a China-based biotechnology company, to...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Barcelona, Spain, August 9, 2026 Almirall announced a collaboration and licensing agreement with CrystalO, a China-based biotechnology company, to...
Boston, MA, August 9, 2026 Asimov announced the successful completion of a cell line development campaign in collaboration with...
WALTHAM, Mass., July 24, 2026 Nova Biomedical has announced the acquisition of certain assets of NanoCellect, a recognized developer...
ZURICH, Switzerland, July 2, 2026 VERAXA Biotech AG announced the initiation of cell line development for its lead BiTAC®...
